Gilead Sciences: Sovaldi Still Selling

This week’s numbers of Gilead Sciences’ (GILD) Sovaldi are in–and the Hepatitis C treatment is still selling. Leerink’s Howard Liang and team explain: Associated Press/Gilead Sciences For the week of 8.22.14, Sovaldi TRx was 6,804, representing 0.8% increase w/w after last week’s 2.1% decrease. This week’s TRx is above what is implied by our and [...]